Technical Analysis for CRL - Charles River Laboratories International, Inc.

Grade Last Price % Change Price Change
C 288.22 1.85% 5.24
CRL closed up 1.85 percent on Wednesday, February 24, 2021, on 81 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Flat
Historical CRL trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 1.85%
20 DMA Support Bullish 1.85%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.85%
Calm After Storm Range Contraction 1.85%
Down 3 Days in a Row Weakness 1.85%
Down 4 Days in a Row Weakness 1.85%
Hammer Candlestick Bullish 1.63%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.63%
Calm After Storm Range Contraction 1.63%
Down 3 Days in a Row Weakness 1.63%
Older End-of-Day Signals for CRL ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Resistance about 4 hours ago
Rose Above 10 DMA about 5 hours ago
Up 2% about 5 hours ago
Up 1% about 6 hours ago
60 Minute Opening Range Breakout about 7 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Charles River Laboratories International, Inc. Description

Charles River Laboratories International, Inc., together with its subsidiaries, provides research models and associated services, and outsourced preclinical services to accelerate the drug discovery and development process. It operates in two segments, Research Models and Services (RMS), and Preclinical Services (PCS). The RMS segment is involved in the production and sale of research model strains, principally genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also offers a range of services to assist customers in the drug discovery and development process, which include genetically engineered models and services, insourcing solutions, discovery research services, research animal diagnostic services, endotoxin and microbial detection products and services, and avian vaccine products and services. The PCS segment provides preclinical services, including both in vivo and in vitro studies, supportive laboratory services, and strategic preclinical consulting and program management to support product development. This segment offers services in the areas of bioanalysis, pharmacokinetics, and drug metabolism; toxicology; and pathology services, as well as testing of biologics and devices frequently outsourced by pharmaceutical and biotechnology companies. The company serves pharmaceutical companies, biotechnology companies, government agencies, hospitals, and academic institutions worldwide. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Life Sciences Pharmaceutical Pharmaceutical Industry Drug Discovery Research Services Wilmington Lab Testing In Vitro Metabolism Laboratory Services Toxicology Pathology Diagnostic Services Pharmacokinetics Clinical Services Contract Research Organizations Detection Products Pre Clinical Development Toxicology Testing Vaccine Products Drug Metabolism Pathology Services

Is CRL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 303.79
52 Week Low 95.58
Average Volume 314,060
200-Day Moving Average 223.50
50-Day Moving Average 266.56
20-Day Moving Average 278.25
10-Day Moving Average 288.57
Average True Range 9.04
ADX 22.25
+DI 25.21
-DI 18.56
Chandelier Exit (Long, 3 ATRs ) 276.67
Chandelier Exit (Short, 3 ATRs ) 276.60
Upper Bollinger Band 302.85
Lower Bollinger Band 253.64
Percent B (%b) 0.7
BandWidth 17.68
MACD Line 6.62
MACD Signal Line 6.93
MACD Histogram -0.3028
Fundamentals Value
Market Cap 14.34 Billion
Num Shares 49.7 Million
EPS 6.00
Price-to-Earnings (P/E) Ratio 48.06
Price-to-Sales 4.03
Price-to-Book 5.94
PEG Ratio 1.70
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 303.74
Resistance 3 (R3) 302.33 295.76 301.15
Resistance 2 (R2) 295.76 291.80 296.46 300.29
Resistance 1 (R1) 291.99 289.36 293.87 293.39 299.43
Pivot Point 285.41 285.41 286.35 286.11 285.41
Support 1 (S1) 281.64 281.46 283.53 283.05 277.01
Support 2 (S2) 275.07 279.02 275.77 276.15
Support 3 (S3) 271.30 275.07 275.29
Support 4 (S4) 272.70